# FDA Inspection 1088132 - Vitalant - April 29, 2019

Source: https://www.keypedia.com/records/fda_inspections/vitalant/9dcffdbf-f3c8-494e-ad01-1978cbd8171e
Source feed: FDA_Inspections

> FDA Inspection 1088132 for Vitalant on April 29, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1088132
- Company Name: Vitalant
- Inspection Date: 2019-04-29
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1021902 - 2017-08-11](https://www.keypedia.com/records/fda_inspections/vitalant/200cce24-b016-4b7b-857a-7d22c442a7cd)
- [FDA Inspection 906093 - 2014-12-02](https://www.keypedia.com/records/fda_inspections/vitalant/070cdd3b-0d62-459e-9bbd-750ab84dda32)
- [FDA Inspection 827228 - 2013-04-05](https://www.keypedia.com/records/fda_inspections/vitalant/3c125483-dbf4-445f-97a3-a92b0446885a)
- [FDA Inspection 701075 - 2010-10-26](https://www.keypedia.com/records/fda_inspections/vitalant/18f6d529-10e2-422e-abe7-5228de12ec89)
- [FDA Inspection 550814 - 2008-12-08](https://www.keypedia.com/records/fda_inspections/vitalant/c34068b6-2e61-4a37-8d90-a77c87e07214)

Company: https://www.keypedia.com/companies/vitalant/b15843ff-ed37-4dd0-b3ed-ead7ece165aa

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d